EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunohistochemical expression of Ki67, CD10, BRAF, and α-SMA tumour markers in ameloblastoma and odontogenic keratocyst

C Chen, T Taheri, M Batstone, N Johnson

International Journal of Oral and Maxillofacial Surgery · 2025

DOI: 10.1016/j.ijom.2025.06.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oral and Maxillofacial Surgery, 2025. Verfasst von C Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia; Oral and Maxillofacial Unit, The Royal Brisbane and Women's Hospi…. Hauptthemen laut MEDLINE: Ameloblastoma, Biomarkers, Tumor, Proto-Oncogene Proteins B-raf, Odontogenic Cysts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Certain tumour markers may play a role in the pathogenesis of ameloblastoma and odontogenic keratocyst (OKC), and may aid the initial diagnostic assessment in selected cases, or possibly serve as prognostic indicators. An immunohistochemical (IHC) study was undertaken to observe the staining patterns of Ki67, CD10, BRAF, and α-SMA tumour biomarkers in relation to ameloblastoma and OKC. Patients treated for ameloblastoma or OKC at the Royal Brisbane and Women's Hospital between January 1, 2008 and December 31, 2020, inclusive, were included. Selected paraffin tissue blocks were retrieved, and slides underwent IHC staining for Ki67 and CD10 (both OKC and ameloblastoma cases) and for BRAF and α-SMA (ameloblastoma cases). Differences were observed in CD10 expression between lesions, with inflammation influencing increased expression in OKC, while unicystic ameloblastoma was usually CD10-positive (87.5%) regardless of inflammation. CD10 and BRAF demonstrated significant differences in location, both presenting higher in mandibular than maxillary ameloblastoma. The study findings suggest that some tumour markers may assist as diagnostic tools in odontogenic lesions; however, tumour marker expression did not demonstrate utility as a prognostic biomarker in ameloblastoma or OKC, where treatment decisions likely played a larger role in the risk of recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmeloblastomaBiomarkers, TumorProto-Oncogene Proteins B-rafOdontogenic CystsKi-67 AntigenNeprilysinActinsJaw NeoplasmsHumansFemaleImmunohistochemistryMaleAdultMiddle AgedAged

Stichwörter der Autor:innen

AmeloblastomaBiomarkersImmunohistochemistryLocal neoplasm recurrenceOdontogenic cystsOdontogenic tumorsTumor

Substanzen

Biomarkers, TumorProto-Oncogene Proteins B-rafKi-67 AntigenNeprilysinBRAF protein, humanActinsACTA2 protein, human

Autor:innen und Institutionen

  • School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia; Oral and Maxillofacial Unit, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. Electronic address: cheryl.chen@…
  • Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Department of Anatomical Pathology, Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Oral and Maxillofacial Unit, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia; Oral and Maxillofacial Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Zitieren

APA

Chen, C., Taheri, T., Batstone, M., & Johnson, N. (2025). Immunohistochemical expression of Ki67, CD10, BRAF, and α-SMA tumour markers in ameloblastoma and odontogenic keratocyst. International Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.ijom.2025.06.012

Vancouver

Chen C, Taheri T, Batstone M, Johnson N. Immunohistochemical expression of Ki67, CD10, BRAF, and α-SMA tumour markers in ameloblastoma and odontogenic keratocyst. International Journal of Oral and Maxillofacial Surgery. 2025. doi:10.1016/j.ijom.2025.06.012

BibTeX
@article{Chen2025,
  author = {Chen, C and Taheri, T and Batstone, M and Johnson, N},
  title = {Immunohistochemical expression of Ki67, CD10, BRAF, and α-SMA tumour markers in ameloblastoma and odontogenic keratocyst},
  journal = {International Journal of Oral and Maxillofacial Surgery},
  year = {2025},
  doi = {10.1016/j.ijom.2025.06.012}
}
Kostenlos starten →